The share

Dicot Pharma's share was first listed in 2018 on Spotlight Stock Market and has been listed on Nasdaq First North since November 2024. At end of first half 2025, we had over 12,700 shareholders, and a total share capital of SEK 14,065,397.514 distributed across 2,009,342,502 shares.

Nasdaq requires that all companies whose shares are admitted to trading on Nasdaq First North must engage a specially approved adviser who acts as a support for the companies and as an intermediary in contact with Nasdaq, a so-called Certified Adviser. Dicot Pharma engages FNCA Sweden AB for the role of Certified Adviser. Contact details: FNCA Sweden AB, Box 5216, SE-102 45 Stockholm, Sweden. Phone + 46 8 528 00 399. E-mail [email protected].